ImmuCell Retained Earnings (Accumulated Deficit) 2010-2025 | ICCC
ImmuCell retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| ImmuCell Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-14 |
| 2023 | $-12 |
| 2022 | $-6 |
| 2021 | $-4 |
| 2020 | $-4 |
| 2019 | $-3 |
| 2018 | $-1 |
| 2017 | $1 |
| 2016 | $1 |
| 2015 | $1 |
| 2014 | $-1 |
| 2013 | $0 |
| 2012 | $-1 |
| 2011 | $-1 |
| 2010 | $0 |
| 2009 | $0 |
| ImmuCell Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-13 |
| 2024-12-31 | $-14 |
| 2024-09-30 | $-15 |
| 2024-06-30 | $-14 |
| 2024-03-31 | $-12 |
| 2023-12-31 | $-12 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $-10 |
| 2023-03-31 | $-9 |
| 2022-12-31 | $-6 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $-4 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $-4 |
| 2020-12-31 | $-4 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-3 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $-1 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $1 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $2 |
| 2017-03-31 | $2 |
| 2016-12-31 | $1 |
| 2016-09-30 | $1 |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | $1 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $-1 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-1 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $-1 |
| 2012-09-30 | $-1 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.057B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.771B | 27.51 |
| Boston Scientific (BSX) | United States | $153.093B | 38.33 |
| Stryker (SYK) | United States | $149.084B | 31.17 |
| EssilorLuxottica (ESLOY) | France | $130.144B | 0.00 |
| Medtronic (MDT) | Ireland | $114.429B | 16.22 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.231B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.710B | 24.95 |
| ResMed (RMD) | United States | $36.952B | 27.75 |
| GE HealthCare Technologies (GEHC) | United States | $34.062B | 16.17 |
| Agilent Technologies (A) | United States | $32.082B | 20.92 |
| Terumo (TRUMY) | Japan | $24.207B | 31.44 |
| Koninklijke Philips (PHG) | Netherlands | $23.216B | 16.29 |
| Insulet (PODD) | United States | $20.408B | 80.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.604B | 11.95 |
| Baxter (BAX) | United States | $14.497B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.846B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.731B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.622B | 14.18 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.585B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.358B | 27.90 |
| ICU Medical (ICUI) | United States | $3.113B | 22.96 |
| QuidelOrtho (QDEL) | United States | $1.890B | 13.00 |
| LeMaitre Vascular (LMAT) | United States | $1.858B | 41.53 |
| AtriCure (ATRC) | United States | $1.512B | 0.00 |
| Acuren (TIC) | United States | $1.407B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.245B | 28.00 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.83 |
| AdaptHealth (AHCO) | United States | $1.205B | 12.23 |
| Neogen (NEOG) | United States | $1.079B | 13.81 |
| BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.836B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.660B | 0.00 |
| Owens & Minor (OMI) | United States | $0.600B | 4.98 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.597B | 0.00 |
| CeriBell (CBLL) | United States | $0.569B | 0.00 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Surmodics (SRDX) | United States | $0.448B | 0.00 |
| SNDL (SNDL) | Canada | $0.397B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Quanterix (QTRX) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.83 |
| ZimVie (ZIMV) | United States | $0.246B | 11.19 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.231B | 61.00 |
| Biote (BTMD) | United States | $0.216B | 6.06 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.155B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.41 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |